Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Can Berberine Serve As a New Therapy for Parkinson’S Disease? Publisher Pubmed



Dadgostar E1, 2 ; Moghanlou M3 ; Parvaresh M4 ; Mohammadi S5 ; Khandan M6 ; Aschner M7 ; Mirzaei H8 ; Tamtaji OR9, 10
Authors

Source: Neurotoxicity Research Published:2022


Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neurodegeneration and deposition of alpha-synuclein. Mechanisms associated with PD etiology include oxidative stress, apoptosis, autophagy, and abnormalities in neurotransmission, to name a few. Drugs used to treat PD have shown significant limitations in their efficacy. Therefore, recent focus has been placed on the potential of active plant ingredients as alternative, complementary, and efficient treatments. Berberine is an isoquinoline alkaloid that has shown promise as a pharmacological treatment in PD, given its ability to modulate several molecular pathway associated with the disease. Here, we review contemporary knowledge supporting the need to further characterize berberine as a potential treatment for PD. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
10. Neuroinflammation As a Potential Therapeutic Target in Neuroimmunological Diseases, Translational Neuroimmunology: Neuroinflammation: Volume 7 (2023)
16. Berberine and Lung Cancer: From Pure Form to Its Nanoformulations, Asia-Pacific Journal of Clinical Oncology (2024)
19. Effects of Berberine on Leukemia With a Focus on Its Molecular Targets, Anti-Cancer Agents in Medicinal Chemistry (2022)